Knowles NYSE: KN has reshaped its portfolio around specialty electronic components for medical technology, defense and industrial markets, Chief Executive Officer Jeff Niew said during an investor presentation. The company has divested lower-margin, more commoditized operations and is emphasizing customized products, margin expansion and cash generation.
Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Knowles (KN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Knowles NYSE: KN reported second-quarter 2026 results above its guidance range, with management pointing to broad-based demand across its Precision Devices business and steady performance in MedTech & Specialty Audio.
Knowles Corporation (KN) Q2 2026 Earnings Call Transcript
Knowles (KN) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.24 per share a year ago.
KN is riding the demand for voice-enabled devices, edge AI and IoT, as its audio tech, acquisitions and efficiency efforts support long-term growth.
Does Knowles (KN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Knowles Corporation (KN) Q1 2026 Earnings Call Transcript
Knowles (KN) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.18 per share a year ago.
Knowles Corporation (KN) Q4 2025 Earnings Call Transcript
Knowles Corporation delivered high-quality Q3 2025 earnings, with fundamentals trending positively and no reliance on one-time items or cost relief. Precision Devices is now KN's earnings engine, showing broad-based growth, improved operating leverage, and a 35–40% drop-through on incremental revenue. MedTech & Specialty Audio segment provides stability, maintaining strong 44% EBITDA margins and reducing downside risk despite muted growth.